Literature DB >> 18056834

Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBPbeta-deficient hematopoietic cells.

Tadayuki Akagi1, Takayuki Saitoh, James O'Kelly, Shizuo Akira, Adrian F Gombart, H Phillip Koeffler.   

Abstract

Transcription factors known as CCAAT enhancer binding proteins (C/EBPs) are involved in hematopoietic differentiation, including myelopoiesis and granulopoiesis. C/EBPbeta-deficient mice develop normally; however, they exhibit defective macrophage function, resulting in increased susceptibility to infection. Little is known about the role of C/EBPbeta in granulopoiesis; therefore, we examined granulopoiesis in C/EBPbeta-deficient mice. Morphology, the number of peripheral blood and bone marrow cells, and the expression of genes specific for the myeloid lineage were normal in C/EBPbeta-deficient mice. Interestingly, the hematopoietic progenitor cells of C/EBPbeta-deficient mice did not respond normally to granulocyte/macrophage-colony stimulating factor and granulocyte colony stimulating factor. In addition, C/EBPbeta-deficient neutrophils displayed enhanced apoptosis compared with wild-type neutrophils. Our present results indicate that C/EBPbeta helps regulate survival of neutrophils, downstream of the granulocyte colony stimulating factor receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056834      PMCID: PMC2265449          DOI: 10.1182/blood-2007-04-087213

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

Review 1.  McBindall--a better name for CCAAT/enhancer binding proteins?

Authors:  S L McKnight
Journal:  Cell       Date:  2001-11-02       Impact factor: 41.582

2.  Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.

Authors:  D Xie; K Nakachi; H Wang; R Elashoff; H P Koeffler
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

3.  CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.

Authors:  Songyun Zhu; Kyungsil Yoon; Esta Sterneck; Peter F Johnson; Robert C Smart
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

Review 4.  The role of C/EBP(epsilon) in the terminal stages of granulocyte differentiation.

Authors:  J A Lekstrom-Himes
Journal:  Stem Cells       Date:  2001       Impact factor: 6.277

5.  C/EBP-beta, C/EBP-delta, PU.1, AML1 genes: mutational analysis in 381 samples of hematopoietic and solid malignancies.

Authors:  Vijaya Vegesna; Seisho Takeuchi; Wolf-K Hofmann; Takayuki Ikezoe; Sigal Tavor; Utz Krug; Anthony C Fermin; Anthony Heaney; Carl W Miller; H Phillip Koeffler
Journal:  Leuk Res       Date:  2002-05       Impact factor: 3.156

6.  C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival.

Authors:  M Buck; V Poli; T Hunter; M Chojkier
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

7.  STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils.

Authors:  Athanasia D Panopoulos; Ling Zhang; Jonathan W Snow; Daniel M Jones; Amber M Smith; Karim C El Kasmi; Fulu Liu; Mark A Goldsmith; Daniel C Link; Peter J Murray; Stephanie S Watowich
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

8.  Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice.

Authors:  James O'Kelly; Junichi Hisatake; Yasako Hisatake; June Bishop; Anthony Norman; H Phillip Koeffler
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

9.  C/EBP beta gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages.

Authors:  Barbara Gorgoni; Diego Maritano; Paola Marthyn; Marco Righi; Valeria Poli
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

10.  Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias.

Authors:  Adrian F Gombart; Wolf-K Hofmann; Seiji Kawano; Seisho Takeuchi; Utz Krug; Scott H Kwok; Renee J Larsen; Hiroya Asou; Carl W Miller; Dieter Hoelzer; H Phillip Koeffler
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

View more
  24 in total

1.  Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells.

Authors:  Min-Hee Oh; Im-Hong Sun; Liang Zhao; Robert D Leone; Im-Meng Sun; Wei Xu; Samuel L Collins; Ada J Tam; Richard L Blosser; Chirag H Patel; Judson M Englert; Matthew L Arwood; Jiayu Wen; Yee Chan-Li; Lukáš Tenora; Pavel Majer; Rana Rais; Barbara S Slusher; Maureen R Horton; Jonathan D Powell
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

2.  Frontline Science: Myeloid cell-specific deletion of Cebpb decreases sepsis-induced immunosuppression in mice.

Authors:  Melissa B McPeak; Dima Youssef; Danielle A Williams; Christopher L Pritchett; Zhi Q Yao; Charles E McCall; Mohamed El Gazzar
Journal:  J Leukoc Biol       Date:  2017-05-05       Impact factor: 4.962

3.  C/EBP-beta regulates endoplasmic reticulum stress-triggered cell death in mouse and human models.

Authors:  Ofir Meir; Efrat Dvash; Ariel Werman; Menachem Rubinstein
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

Review 4.  Emergency granulopoiesis.

Authors:  Markus G Manz; Steffen Boettcher
Journal:  Nat Rev Immunol       Date:  2014-04-22       Impact factor: 53.106

5.  Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer.

Authors:  Wei Li; Takashi Tanikawa; Ilona Kryczek; Houjun Xia; Gaopeng Li; Ke Wu; Shuang Wei; Lili Zhao; Linda Vatan; Bo Wen; Pan Shu; Duxin Sun; Celina Kleer; Max Wicha; Michael Sabel; Kaixiong Tao; Guobin Wang; Weiping Zou
Journal:  Cell Metab       Date:  2018-05-24       Impact factor: 27.287

6.  C/EBPβ is a critical mediator of IFN-α-induced exhaustion of chronic myeloid leukemia stem cells.

Authors:  Asumi Yokota; Hideyo Hirai; Ryuichi Sato; Hiroko Adachi; Fumiko Sato; Yoshihiro Hayashi; Atsushi Sato; Naoka Kamio; Yasuo Miura; Masakazu Nakano; Daniel G Tenen; Shinya Kimura; Kei Tashiro; Taira Maekawa
Journal:  Blood Adv       Date:  2019-02-12

7.  In vivo deficiency of both C/EBPβ and C/EBPε results in highly defective myeloid differentiation and lack of cytokine response.

Authors:  Tadayuki Akagi; Nils H Thoennissen; Ann George; Gay Crooks; Jee Hoon Song; Ryoko Okamoto; Daniel Nowak; Adrian F Gombart; H Phillip Koeffler
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

8.  C/EBPβ promotes BCR-ABL-mediated myeloid expansion and leukemic stem cell exhaustion.

Authors:  Y Hayashi; H Hirai; N Kamio; H Yao; S Yoshioka; Y Miura; E Ashihara; Y Fujiyama; D G Tenen; T Maekawa
Journal:  Leukemia       Date:  2012-09-05       Impact factor: 11.528

9.  Effects of 5-fluorouracil chemotherapy on fatigue: role of MCP-1.

Authors:  S E Mahoney; J M Davis; E A Murphy; J L McClellan; B Gordon; M M Pena
Journal:  Brain Behav Immun       Date:  2012-10-17       Impact factor: 7.217

10.  Prostaglandin E2 Enhances Aged Hematopoietic Stem Cell Function.

Authors:  Andrea M Patterson; P Artur Plett; Carol H Sampson; Edward Simpson; Yunlong Liu; Louis M Pelus; Christie M Orschell
Journal:  Stem Cell Rev Rep       Date:  2021-05-11       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.